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Human immunodeficiency virus type I (HIV-1) DNA integration is an essential step of viral replication. We have suggested recently that
this stage of HIV-1 life-cycle triggers a cellular DNA damage response and requires cellular DNA repair proteins for its completion. These
include DNA-PK (DNA-dependent protein kinase), ATR (ataxia telangiectasia and Rad3-related), and, at least in some circumstances, ATM
(ataxia telangiectasia mutated). Host cell proteins may constitute an attractive target for anti-HIV-1 therapeutics, since development of drug
resistance against compounds targeting these cellular cofactor proteins is unlikely. In this study, we show that an inhibitor of ATR and ATM
kinases, caffeine, can suppress replication of infectious HIV-1 strains, and provide evidence that caffeine exerts its inhibitory effect at the
integration step of the HIV-1 life-cycle. We also demonstrate that caffeine-related methylxanthines including the clinically used compound,
theophylline, act at the same step of the HIV-1 life-cycle as caffeine and efficiently inhibit HIV-1 replication in primary human cells. These
data reveal the feasibility of therapeutic approaches targeting host cell proteins and further support the hypothesis that ATR and ATM proteins
are involved in retroviral DNA integration.
D 2005 Elsevier Inc. All rights reserved.
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IntroductionCells posses multiple mechanisms to maintain genomic
integrity in the face of DNA damage (Zhou and Elledge,
2000). Cellular DNA damage response is regulated by two
related kinases, ATM and ATR, which belong to the PI-3K-
related group of kinases. This group of large proteins includes
yeast and mammalian kinases that bear a signature (kinase)
domain at their carboxyl termini. Three members of this
family, DNA-PKCS, ATM, and ATR, have been implicated in
mammalian DNA repair. We had proposed recently that0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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al., 1999). We observed that DNA-PK-deficient cells do not
support efficient transduction by HIV-1-based vectors and
HIV-1 infection triggered apoptosis of these cells in an
integrase-dependent manner (Daniel et al., 1999, 2004a).
Although these observations were not universal and alter-
native models of DNA-PK involvement in HIV-1 infection
were proposed (Baekelandt et al., 2000; Kilzer et al., 2003; Li
et al., 2001), three other laboratories have since demonstrated
that cells deficient in a DNA-PK component, the Ku protein,
do not support efficient HIV-1 DNA integration and
retrotransposition (Downs and Jackson, 1999; Jeanson et
al., 2002; Waninger et al., 2004). These data are consistent
with our original hypothesis. Likewise, we observed very
recently that cells lacking another related kinase, ATR, also
do not support efficient stable HIV-1 integration (Daniel et
al., 2003). In contrast, ATM-lacking cell lines do not seem to05) 177–184
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(Daniel et al., 2001a). ATM role is more subtle and ATM
seems to be required for residual transduction of DNA-PKCS-
deficient cells. However, given that the levels of the DNA-
PKCS proteins vary in human cells and tissues, it is possible
that ATM has a more prominent role in cells with low DNA-
PKCS activity.
The prominent role, which these DNA repair kinases play
in integration, creates an opportunity to suppress HIV-1
replication by targeting host cell proteins. This approach
might be used for treatment of drug-resistant viral strains that
rise as a result of current anti-HIV-1 therapeutic approaches.
In addition, targeting cellular proteins with their low muta-
tional rate may not lead to a rapid emergence of HIV-1 strains
resistant to inhibitors of these proteins.
The ATM and ATR kinases are targets of a known
inhibitor of DNA repair, caffeine (Hall-Jackson et al., 1999;
Sarkaria et al., 1999). Caffeine was shown to inhibit activity
of these kinases in vitro and inhibit cellular DNA damage
responses controlled by ATM and ATR at these concen-
trations in vivo, without an associated cytotoxicity (Wang et
al., 2003; Zhou et al., 2000). Likewise, a number of reports
demonstrated inhibition of ATM- and ATR-mediated phos-
phorylation by caffeine in vivo (Golding et al., 2004; Wang
et al., 2005; Zhou et al., 2000).
Caffeine is 1,3,7-trimethylxanthine and some of caffeine-
related methylxanthines are products of caffeine metabolism
in vivo (paraxanthine, theobromine, and theophylline).
Theophylline is in clinical use for the treatment of asthma.
It has also been demonstrated that at least some methyl-
xanthines exhibit caffeine-like effects on DNA damage
response (Bohm et al., 2003; Sarkaria and Eshleman, 2001).
We found very recently that caffeine inhibits stable
retroviral transduction by HIV-1-based vectors (Daniel et
al., 2003). On the other hand, the Planelles lab (DeHart et al.,
2005) suggested that the caffeine effect on HIV-1 trans-
duction is mediated by inhibition of CMV-driven expression
(DeHart et al., 2005). In a similar manner, another group
reported no effect of caffeine nor ATR siRNA on HIV-1
transduction (Ariumi et al., 2005). In this study, we show that
caffeine and other methylxanthines do in fact suppress
replication of infectious HIV-1 strains and that the integration
step of the HIV-1 life-cycle is the caffeine’s target. These
proof-of-the-principle experiments demonstrate that HIV-1
replication can be successfully suppressed by inhibition of
host cell DNA repair proteins and show the feasibility of this
bindirectQ approach to HIV-1 therapy.Results and discussion
Methylxanthines suppress replication of different HIV-1
strains
To test the effect of methylxanthines on HIV-1
replication, human peripheral blood mononuclear cells(PBMCs) from HIV-1-seronegative individuals were
infected with the T-cell-line-tropic HIV-1 NL4-3 (X4)
strain and simultaneously treated with methylxanthines.
We then performed HIV-1 p24 antigen assays at 3, 7,
and 12 days post-infection. We observed a 9-fold
decrease in HIV-1 p24 antigen values in samples
treated with caffeine and theophylline (1,3-dimethylxan-
thine) when compared to control samples infected with
NL4-3 alone (Fig. 1A). A 3- to 4-fold drop in HIV-1
p24 antigen levels was still observed at 7 days post-
infection in samples treated with caffeine and theophyl-
line, respectively. P24 antigen levels in caffeine- and
theophylline-treated samples reached the control level at
12 days post-infection, which is presumably due to the
removal of the inhibitors from the medium. An
alternative explanation could be that that the drug
anti-viral effect in fact alleviated virus-mediated killing
in cultures, which in turn allowed for continued slow
replication and p24 accumulation. We have also
observed a suppression of HIV-1 replication with
paraxanthine (1,7-dimethylxanthine) and theobromine
(3,7-dimethylxanthine); however, these compounds sup-
pressed HIV-1 replication only 2- to 3-fold at day 3
post-infection when compared with the untreated, NL4-
3-infected control (Fig. 1A). Caffeine, theophylline, and
paraxanthine did not show any significant cellular
cytotoxicity when evaluated by the XTT assay; only
theobromine inhibited the PBMC growth by 40% at the
utilized concentration (data not shown).
To determine if the effects of methylxanthines extend to
different HIV-1 strains, we performed a similar experiment
with the macrophage-tropic (R5) HIV-1 strain, ADA, and
the NL4-3 strain as a control (Fig. 1B). We have also
included in these experiments samples treated with lower
methylxanthine concentrations, including 100 AM, which is
a concentration close to that reached in the plasma of
theophylline-treated patients (28–110 AM, Ohnishi et al.,
2003). Methylxanthines were again added to the medium at
the time of infection and maintained in the media until 6
days post-infection, when HIV-1 p24 antigen levels were
analyzed. As shown in Fig. 1A, methylxanthines inhibited
replication of the rapidly-growing NL4-3 strain at 1 and 4
mM, but not at 100 AM (Fig. 1B, left panel). Caffeine and
theophylline inhibited NL4-3 growth approximately 9-fold
and 5-fold, respectively, at a concentration of 4 mM,
whereas the effect of theobromine was much weaker (about
a 2-fold inhibition), consistent with the data presented in
Fig. 1A. However, replication of the HIV-1 ADA strain
was inhibited even at lower concentrations, with an IC50
close to 60 AM (theophylline) and 100 AM (caffeine and
theobromine) (Fig. 1B, right panel). The most efficient
inhibitor of the HIV-1 ADA strain appeared to be
theophylline, followed by caffeine and theobromine (Fig.
1B, right panel). We conclude that caffeine and related
methylxanthines can suppress replication of fully infectious
HIV-1 strains.
Fig. 1. Caffeine and related methylxanthines suppress replication by HIV-1 NL4-3 and ADA strains. (A) Peripheral blood mononuclear cells (PBMCs) were
infected with the HIV-1 strain NL4-3 and treated with methylxanthines (4 mM concentration), as described in the text and Materials and methods. The level of
p24 antigen in the culture supernatant was measured at 3, 7, and 12 days post-infection. Black line, (E) culture infected with the NL4-3 virus in the absence of
methylxanthines; orange, (o) uninfected cells; red, (!) culture infected with NL4-3 and treated with theobromine; green line, (5) culture infected with NL4-3
and treated with paraxanthine; pale blue, (D) culture infected with NL4-3 and treated with caffeine; dark blue, (n) culture infected with NL4-3 and treated with
theophylline. (B) PBMCs were infected with the NL4-3 and ADA strains and treated with methylxanthines, as described in the text and above. The level of
HIV-1 p24 antigen in the culture supernatant was measured at 6 days post-infection. Left panel, NL4-3-infected culture; right panel, ADA-infected culture. CF,
cells infected with a given HIV-1 strain and treated with caffeine; TP, cells infected with a specific HIV-1 strain and treated with theophylline; TB, cells infected
with a specific HIV-1 strain and treated with theobromine; V, cells infected with a specific HIV-1 strain, no methylxanthine added; U, uninfected cells. Black
columns, a methylxanthine was added to culture; white columns, no methylxanthine was added.
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life-cycle
To determine which steps of the HIV-1 life-cycle are
targeted by methylxanthines, we first analyzed the levels of
HIV-1 DNA, HIV-1 nuclear import, and HIV-1 DNA
integration in infected, caffeine-treated cells. We have
shown previously that caffeine inhibited integration of
vesicular stomatitis virus glycoprotein (VSV G)-pseudo-
typed HIV-1-based vectors (Daniel et al., 2003); however, it
is possible that the effects of caffeine and other methyl-
xanthines are mediated by inhibition of other steps of the
HIV-1 life-cycle in HIV-1 strains carrying the wild-type
HIV-1 envelope. To determine whether caffeine inhibits
HIV-1 DNA synthesis or preceding stages of the HIV-1 life
cycle, we first determined the levels of HIV-1 DNA using a
previously established methodology (Nunnari et al., 2002;
Otero et al., 2003). PBMCs were again infected with the
HIV-1 strain NL4-3 and caffeine was added at the time of
infection. Twenty-four hours after addition of the virus, cellswere harvested and early steps of the HIV-1 life-cycle
analyzed. As shown in Fig. 2A, methylxanthines, even at
the highest utilized concentration (4 mM), did not have any
significant negative effect on the level of HIV-1 DNA in
infected and caffeine-treated cells. To determine if methyl-
xanthines altered the nuclear import of HIV-1 pre-integra-
tion complexes (PICs), we analyzed the level of 2-LTR
DNA junctions in infected cells using again a semi-
quantitative method and comparison with a standard as
described previously (Nunnari et al., 2002; Otero et al.,
2003). No significant inhibitory effect of caffeine on the
level of 2-LTR junctions was demonstrated (Fig. 2B, data
not shown). Then, using Alu-PCR, we investigated the level
of integrated HIV-1 DNA in these samples, as described
recently (Daniel et al., 2003). As a positive control, we used
ACH-2 cells, which carry one copy of latent, integrated
proviral DNA in the cellular genome. When we compared
caffeine-treated and control NL4-3 samples, we detected
approximately 4- to 50-fold less integrated viral DNA in
methylxanthine-treated samples (Fig. 2C). Finally, we
Fig. 2. Effect of caffeine on early steps of the HIV-1 life-cycle. PBMCs were infected with the NL4-3 strain and treated with methylxanthines as described in
Materials and methods. Twenty-four hours post-infection, cells were harvested and analyzed as described in Materials and methods. The relative intensity of
bands was determined by PhosphoImager and densitometry analysis and compared to the intensity of sample infected with the NL4-3 virus, but untreated with
any of the methylxanthines (left panels). (A) Level of gag HIV-1-specific DNA in infected and methylxanthine-treated cultures. (B) Level of HIV-1 2-LTR
DNA circles. (C) Level of viral-host DNA joining as evaluated by Alu-PCR. (D) Level of gag HIV-1 RNA. (E) Control comparison of h-globin DNA level in
analyzed cells. CF, cells infected with NL4-3 and treated with caffeine; TP, cells infected with NL4-3 and treated with theophylline; TB, cells infected with
NL4-3 and treated with theobromine; PX, cells infected with NL4-3 and treated with paraxanthine; V, cells infected with NL4-3, no methylxanthine added; U,
uninfected cells; AC, ACH-2 cells; NA, ACH-2 cells, no Alu primer in the first round of PCR.
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these cells. Since integration begins to occur approximately
4–8 h post-infection (Daniel et al., 2001b; Pryciak et al.,
1992), most HIV-1-specific RNA at the 24 h time-point is
likely due to expression of the integrated provirus. We
observed a decreased unspliced HIV-1-specific RNA level
in cells treated with methylxanthines, which correlate with
the decreased levels of integrated HIV-1 DNA in these
samples (Fig. 2D). Thus, these data indicate that caffeine
inhibits HIV-1 replication at the integration step.
Effect of methylxanthines on late steps of the HIV-1
life-cycle
To determine if methylxanthines affect the late, post-
integrative steps of the HIV-1 life-cycle, we have utilized
the ACH-2 line, which produces HIV-1 particles upon
stimulation with phorbol myristate acetate (PMA). Weobserved that methylxanthines do not affect either
production of HIV-1 virion particles in the culture
supernatant, nor p24 antigen expression in unstimulated
ACH-2 cells (Figs. 3A and B). Likewise, methylxanthines
had no effect on the production of HIV-1 particles and
intracellular p24 antigen levels when ACH-2 cells were
stimulated with PMA (Figs. 3A and B). These data
suggest that these methylxanthines do not suppress HIV-1
replication by inhibition of post-integrative steps of the
HIV-1 life-cycle. Taken together, the target of methyl-
xanthines appears to be HIV-1 DNA integration.
Effect of caffeine and theophylline on phosphorylation of
ATM and ATR substrates
The cellular targets of caffeine are the ATM and ATR
kinases. To establish if HIV-1 infection triggers the DNA
damage response that is controlled by these kinases, we
Fig. 3. Effects of caffeine on late steps of the HIV-1 life-cycle. ACH-2 cells were stimulated with PMA or left unstimulated and treated with methylxanthines at
given concentrations. Twenty-four hours after addition of PMA and methylxanthines, cultures and cells were analyzed. (A) HIV-1 p24 antigen level in the
culture supernatant. (B) Intracellular HIV-1 p24 antigen level. M, mock, no methylxanthine was added; CF, caffeine-treated cells; TP, theophylline-treated cells.
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analyzed the levels of phosphorylation by ATM and ATR in
these cells. As a positive control, we used ds DNA breaks-
inducing drug etoposide (ETP). We observed increased
levels of p53 phosphorylated on serine 15 residue in
infected cells, which is a well-established target of the
ATM and ATR kinases (Fig. 4A). Similarly, we observed
increased phosphorylation of the BRCA1 protein on serine
1423 residue, which is also an ATR and ATM substrate
(Gatei et al., 2000, 2001; Tibbetts et al., 2000) (Fig. 4). Of
importance, p53 and BRCA1 phosphorylations were sup-
pressed by addition of caffeine and also with theophylline
(Fig. 4). Therefore, infection with the replication-competent
HIV-1 strain NL4-3 triggers the ATM- and ATR-dependent
DNA damage response, which is functionally inhibited by
select methylxanthines. Interestingly, these drugs failed to
suppress a basal phosphorylation of BRCA1 on serine 1423
(Fig. 4, left lanes), suggesting a role of caffeine-resistant
kinase in this process. Finally, given that ATR seems to play
a more important role in HIV-1 DNA integration than ATM,
the observed enhanced phosphorylation in HIV-1-infected
cells is likely due to the activation of the ATR kinase
(Daniel et al., 2001a, 2003). Consistently, we have also
shown very recently that an established substrate of ATM
and ATR kinases, the histone H2AX, is phosphorylated at
sites of retroviral DNA integration (Daniel et al., 2004b).In this study, we present data demonstrating that the ATM
and ATR inhibitor caffeine and related methylxanthines can
suppress replication of HIV-1. We have observed that these
compounds inhibit replication of two infectious HIV-1
strains, NL4-3 and ADA. The decrease in the amount of
integrated viral DNA in methylxanthine-treated cultures
suggests that the target of methylxanthines is the integration
step of the HIV-1 life-cycle. The decrease could be due to
inefficient joining of viral to host DNA. This step of HIV-1
integration is catalyzed by HIV-1 integrase; however, we did
not detect any effect of caffeine on this enzyme, even at 10
mM concentration (Daniel et al., 2003). This finding and
presented data suggest that the effect of caffeine is mediated
by inhibition of its cellular target, the ATR kinase. The role
of ATR in integration is at present unclear. ATR plays an
integral role in the cellular DNA damage response and a
deficiency in ATR activity sensitizes cells to killing by DNA
damaging agents (Cliby et al., 1998). It thus seems likely that
the decrease of integrated HIV-1 DNA in methylxanthine-
treated cultures reflects increased cell killing due to an
abortive integration, which cannot be completed in cells
deficient in ATR activity. Indeed, we have observed an
integrase-dependent killing of ATR-deficient cells that were
infected with avian sarcoma virus-based vectors (Daniel et
al., 2003). One could possibly imagine two roles for the ATR
kinase in integration. One is the repair of single-stranded
Fig. 4. Caffeine suppresses ATR- and ATM-mediated phosphorylation.
PBMCs were infected with the NL4-3 virus and treated with caffeine and
theophylline, as described in Materials and methods, and harvested 24 h
later. Cell lysates were subjected to Western blotting analysis to detect the
BRCA1 phosphorylated on serine 1423 and the p53 protein phosphorylated
on serine 15. The level of Ku 86 protein served as a loading control. M,
mock, no methylxanthine added; CF, caffeine-treated cells; TP, theophyl-
line-treated cells.
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Alternatively, it is possible that ATR plays a role in the
chromatine assembly that follows the joining of viral to host
DNA. Our future experiments will address these questions.
ATR is an essential protein and its complete deletion is
known to result in cell death (Brown and Baltimore, 2000;
Cortez et al., 2001; de Klein et al., 2000). However, we
observed efficient suppression of HIV-1 replication at
concentrations that were not detrimental to primary human
cells. This finding likely indicates that only a small, residual
level of the ATR activity is necessary to maintain cell
viability and thus ATR still can be a target for inhibition of
HIV-1 infection. Indeed, inhibition of ATR by a trans-
dominant negative ATR mutant is known to inhibit ATR-
controlled DNA repair without compromising cell viability
(Cliby et al., 1998). Of course, the highest concentrations of
methylxanthines that we used (4 mM) would be toxic when
used in humans, although, interestingly, treatment with
theophylline had a significant effect on HIV-1 replication
even at concentrations that are observed in the plasma of
patients that use theophylline for treatment of other diseases
(Ohnishi et al., 2003). Nevertheless, more efficient inhib-
itors of the cellular DNA repair kinases will have to be
developed and potential side effects investigated for full
clinical use in treatment of HIV-1 infection. However, the
presented proof-of-principle experiments suggest that tar-
geting host cell proteins could be a viable approach for
antiretroviral therapy.Materials and methods
Chemicals
Caffeine, theobromine, theophylline, and paraxanthine
were obtained from Sigma (St. Louis, MO). The stock
concentration was 100 mM. Caffeine was dissolved in
water, whereas theophylline, theobromine, and paraxanthine
were dissolved in 0.1 N NaOH. NaOH had no effect on
HIV-1 replication at the concentrations which were utilized
(data not shown).Cell cultures, HIV-1 strains, and infections
PBMCs from HIV-1-seronegative donors were separated
from blood plasma by discontinuous Ficoll-Hypaque
(Sigma, St. Louis, MO) centrifugation. CD8+ T-lympho-
cytes were depleted from isolated PBMCs by binding with
magnetic beads conjugated anti-CD8 antibody (Miltenyi
Biotec Inc., Auburn, CA). This process decreases the
fraction of CD8+ T-lymphocytes in PBMCs from approx-
imately 20–30% to 3–5%, as analyzed by flow cytometry
(Otero et al., 2003). Macrophages and their precursors were
also depleted from PBMCs by incubating the samples
overnight to allow these cells to attach to the plastic plates.
1.5  106 CD8+ T-lymphocyte/monocyte-depleted
PBMCs from HIV-1-seronegative donors were cultured in
RPMI 1640 medium with 10% fetal calf serum (FCS) and
penicillin plus streptomycin at 37 8C, stimulated with 5 Ag
of phytohemagglutinin (PHA) per milliliter (Sigma), and 50
U of interleukin-II (IL-2) per milliliter (GIBCO-BRL, Grand
Island, NY).
Two different laboratory strains, NL4-3 or ADA, T-cell-
line (X4) and monocyte (R5) tropic, respectively, were used
for infection. 10 ng/ml of HIV-1 p24 antigen equivalents
was utilized to infect 1.5  106 CD8+ T-lymphocyte/
monocyte-depleted PBMCs. Infected cells were simulta-
neously treated with four different types of methylxanthines
(caffeine, theophylline, theobromine, paraxanthine) at var-
ious concentrations: 100 AM, 1 mM, 2 mM, and 4 mM.
After overnight infection, cells were washed thoroughly
three times to remove excess of viral inputs and methyl-
xanthines were added one more time. Cells were then
cultured for 12 days and supernatants were collected at 3
different time-points and stored frozen until use.
HIV-1 p24 antigen levels were measured in the super-
natants by enzyme-linked immunosorbent assay (ELISA)
(Dupont, Wilmington, DE). Positive cultures were defined
as those demonstrating at least 30 pg/ml of HIV-1 p24
antigen in the culture supernatant. All procedures were
performed under level P3 biosafety conditions to minimize
the possibility of cross-contamination.
Quantitative HIV-1 DNA and RNA analyses
After overnight infection, cells were harvested and
washed thoroughly three times to remove excess viral
inputs. The cellular RNA and DNA were extracted as
described previously (Nunnari et al., 2002). The presence of
intracellular unspliced viral RNA was analyzed utilizing a
super-sensitive reverse transcriptase-polymerase chain reac-
tion (RT-PCR) and Southern blotting assays for HIV-1 gag
sequences, using the primer-probe set SK38, SK39, and
SK19. Southern blotting was utilized to visualize the
specific bands and compared with a serially-diluted standard
curve to quantitate viral unspliced RNA to 5 copies, with
detection but not quantification between 1 and 5 copies, as
described previously (Nunnari et al., 2002). The same set of
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(Nunnari et al., 2002). To normalize the cell number, the
human beta-globin gene was quantitated from these cells
(Otero et al., 2003).
HIV-1 2-LTR DNA circle analyses
HIV-1 2-LTR DNA circles were analyzed by a
quantitative DNA-PCR technique. The following sense
and anti-sense primers were utilized, as we described
previously (Nunnari et al., 2002): 5V-GTAACTAGAGA-
TACCCTCAAC-3V and 5V-CAGATCTGGTCTAACCAGA-
GA-3V. A specific primer that is contained in the amplicon
of the 2-LTR DNA circle junction (5V-AGTGGCGAGCCC-
TCAGATGCTGC-3V) was labeled with 32P for Southern
blotting analysis. To normalize the cell number, the human
beta-globin gene was quantitated from these cells (Otero
et al., 2003).
ACH-2 cell culture and post-integrative studies
ACH-2 cells, a latent T-cell-line containing one inte-
grated copy of HIV-1 genome, were obtained from AIDS
Reagent Repository and were utilized to investigate whether
caffeine and theophylline have an effect at a post-integrative
phase of the HIV-1 life-cycle. 1  106 cells were stimulated
with 1 Ag of phorbol 12-myristate 13-acetate (PMA) or left
untreated and cultured in the presence of 100 AM, 1 and 4
mM of caffeine and theophylline. Cell culture supernatants
were collected at 24 h after treatment. HIV-1 p24 antigen
was measured in the supernatants, as described above.
Alu-PCR
To determine the efficiency of joining of HIV-1 and host
cell DNA, PBMCs were infected with the NL4-3 viral strain
(10 ng p24 antigen equivalents per sample), as described
above, for quantitative HIV-1 DNA analysis. After overnight
infection, cells were harvested, cellular DNA extracted, and
1 Ag DNA per sample was used for the Alu-PCR analysis.
The nested Alu-PCR assay was performed in a PE 9700
system, under conditions and using primers described
previously, except the second round of PCR was performed
for 45 cycles, instead of 25 (Daniel et al., 2003).
Western blot analyses
To detect phosphorylated BRCA1 and p53 proteins, 106
PBMCs were first infected with 100 ng of the HIV-1 NL4-3
strain and treated with 4 mM caffeine or theophylline. As a
positive control, cells were treated with etoposide (125 Ag/
ml). Cells were harvested 16 h later, lysed, and lysates
subjected to Western blot analysis. For detection of the
BRCA1 protein phosphorylated on serine 1423 residue and
the Ku86 protein, a cell lysate from 5  105 cells was
resolved on an SDS–PAGE and Western blotting wassequentially performed with an anti pBRCA1 (Bethyl
Laboratories, Montgomery, TX, cat # A300-008A) or an
anti-Ku86 antibody (Santa Cruz, sc-9034, Santa Cruz, CA).
For detection of the p53 phosphorylated on serine 15
residue, Western blotting was performed with a rabbit
polyclonal antibody from Cell Signaling Technology,
Beverly, MA (cat # 9284S).Acknowledgments
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